NetNoggin® releases exploratory analysis “Is TRIKAFTA a true ‘game changer’?”

FREDERICK, Md., Aug. 6, 2020 /PRNewswire/ — A new exploratory study, conducted by NetNoggin®, highlights patient and caregiver reported change in lung function, expectations, and lexicon for patients who have been on TRIKAFTA.

Marketing Director of NetNoggin®, Megan Newcomer, explains, “We’ve been tracking how TRIKAFTA has influenced the cystic fibrosis community in our new report, NetNog: #genesis® Cystic Fibrosis V2.0, but we wanted to release an exploratory study that analyzes if this market disruptor is truly perceived as a ‘game changer’ now that it has been on the market for more than nine months. We did an exploratory study shortly after TRIKAFTA was launched in October 2019, and saw the excitement and lexicon themes around TRIKAFTA being a ‘game changer.’ We thought it was appropriate now to look at TRIKAFTA again and compare the results to those we originally saw in October.”

The results of this exploratory analysis show that while TRIKAFTA met and even exceeded expectations for many patients, others were less satisfied by its effect. Visit https://netnoggin.net/exploratory-analysis to request the full exploratory analysis.

Additional results for TRIKAFTA’s disruption can be found in NetNoggin‘s syndicated, comprehensive report, NetNog: #genesis® Cystic Fibrosis V2.0, which includes updates to the patient journey due to TRIKAFTA, and puts the TRIKAFTA market disruption into context by highlighting the patient experience of those on TRIKAFTA as well as those not on TRIKAFTA.

For pricing of NetNog: #genesis® Cystic Fibrosis V2.0, contact Megan Newcomer at megan.newcomer@netnoggin.net.

About NetNoggin®
NetNoggin®, a subsidiary of Conger Consulting, LLC, is a premier market research agency that specializes in pharmaceutical marketing. NetNoggin® takes unstructured social data and structures it using their technology and expert personnel (netnographers) who are trained in various disease areas, linguistics, storytelling, pharmaceutical marketing, and science to ensure the context and interpretation of the data is accurate. By leveraging 30+ years of experience, their proprietary process derives strategic consulting insights from big data to inform Foundational Marketing Tools (FMTs), strategies, and tactics. NetNoggin® has expertise in market research; commercial, market, and clinical development; and communications to provide reliable research, presentations, and workshops.

NetNoggin® Media Relations

If you would like more information on this topic, please contact Megan Newcomer at megan.newcomer@netnoggin.net.

View original content to download multimedia:http://www.prnewswire.com/news-releases/netnoggin-releases-exploratory-analysis-is-trikafta-a-true-game-changer-301107830.html

SOURCE NetNoggin

Staff

Recent Posts

Phio Pharmaceuticals Announces Reverse Stock Split

Marlborough, Massachusetts--(Newsfile Corp. - July 2, 2024) - Phio Pharmaceuticals Corp. (Nasdaq: PHIO) (the "Company"),…

4 hours ago

Alafair Biosciences Awarded Synthetic Implantable Products Agreement with Premier, Inc. for VersaWrap® Hydrogel Sheet

AUSTIN, Texas, July 2, 2024 /PRNewswire/ -- Alafair Biosciences, Inc., is revolutionizing soft tissue protection…

4 hours ago

PillBot™: Micro-robotics now inside the Human Body

HAYWARD, Calif., July 2, 2024 /PRNewswire/ -- Endiatx, a pioneering Silicon Valley medical technology company,…

4 hours ago

Digital Pathology Scanner Market Size to Grow USD 1,137 Million by 2030 at a CAGR of 10.31% | Valuates Reports

BANGALORE, India, July 2, 2024 /PRNewswire/ -- Digital Pathology Scanner Market is Segmented by Type (Fluorescence,…

4 hours ago

Medicus IT Ranked on Channel Futures 2024 MSP 501–Tech Industry’s Most Prestigious List of Managed Service Providers Worldwide

ALPHARETTA, Ga., July 2, 2024 /PRNewswire/ -- Medicus IT has been named as one of the…

4 hours ago